Literature On Meibomian Gland Dysfunction And Eyelid Hygiene
Revisiting the Vicious Circle of Dry Eye Disease: a Focus on the Pathophysiology of Meibomian Gland Dysfunction
Meibomian gland dysfunction (MGD) is the most frequent cause of dry eye disease (DED). Eyelid inflammation, microbial growth, associated skin disorders
as well as potentially severe corneal complications culminate to make MGD a complex multifactorial disorder.
Reduction in Bacterial Load Using Hypochlorous Acid Hygiene Solution on Ocular Skin
Purpose: To examine the magnitude ofbacterial load reduction on the surface of the periocular skin 20 minutes after application of a saline hygiene solution containing 0.01 % pure hypochlorous acid (HOC!).
Literature On The Effectiveness of Avenova and Hypochlorous Acid 0.01%
Time-Kill Comparison of Povidone Iodine to Hypochlorous Acid against Endophthalmitis Isolates of Staphylococci
Purpose: We compared the antibacterial activity of Povidone Iodine (PI) and Hypochlorous Acid (HA) against endophthalmitis isolates of Staphylococcus aureus and coagulase-negative Staphylococcus using time-kill studies.
0.01% Hypochlorous Acid as an Alternative Skin Antiseptic An In Vitro Comparison
Dry eye disease (DED) is a common ocular disorder with multiple contributing factors. It is characterized by inadequate tear production, poor tear quality, or accelerated tear evaporation. The pathogenesis of DED includes tear film imbalances and ocular surface inflammation. These processes can result in symptoms such as dryness, excessive tearing, photophobia, and blurred vision.
Avenova® (pure 0.01% HOCl) compared with OTC product (0.02% HOCl)
Avenova is the only non-detergent based, prescription lid and lash hygiene product containing pure hypochlorous acid.
Avenova Offers Key Benefits in Glaucoma Care
July 31, 2017, Dr. I. Paul Singh, a respected glaucoma specialist at The Eye Centers of Racine and Kenosha, today highlights an important and innovative approach for helping patients manage their glaucoma—a new eyelid hygiene product from NovaBay Pharmaceuticals (NYSE MKT: NBY) called Avenova®.